Full Article: COLDPREV – A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Study on ColdZyme® Mouth Spray against Rhinovirus-Induced Common Cold. Oct 2017
Article: A medical device forming a protective barrier that deactivates four major common cold viruses (Rhinovirus type 1A and type 42, Seasonal Flu virus (H3N2), Respiratory Syncytial Virus, Adenovirus type 2). Nov 2017
Article: Evaluation of ColdZyme Mouth Spray against common cold in preschool staff. Oct 2017
Abstract: Prevention of upper respiratory tract infection among elderly care personnel and residents at a nursing home. Dec 2016
This content needs to be approved before viewing.
Yes, I accept
No, I decline